Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 5 studies | 22% ± 5% |
Insufficient scRNA-seq data for expression of NLRP12 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 282.39 | 576 / 578 | 20% | 0.64 | 232 / 1155 |
prostate | 57% | 15.95 | 139 / 245 | 52% | 1.43 | 263 / 502 |
spleen | 100% | 863.80 | 241 / 241 | 0% | 0 | 0 / 0 |
breast | 80% | 27.58 | 367 / 459 | 16% | 0.32 | 184 / 1118 |
adipose | 95% | 75.38 | 1141 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 5338.63 | 756 / 929 | 0% | 0 | 0 / 0 |
heart | 70% | 27.34 | 605 / 861 | 0% | 0 | 0 / 0 |
bladder | 62% | 23.14 | 13 / 21 | 3% | 0.18 | 15 / 504 |
blood vessel | 63% | 32.66 | 845 / 1335 | 0% | 0 | 0 / 0 |
liver | 62% | 21.05 | 141 / 226 | 0% | 0.01 | 2 / 406 |
uterus | 60% | 18.66 | 102 / 170 | 1% | 0.03 | 6 / 459 |
kidney | 47% | 15.42 | 42 / 89 | 11% | 0.18 | 99 / 901 |
thymus | 56% | 14.83 | 367 / 653 | 1% | 0.01 | 4 / 605 |
adrenal gland | 56% | 13.97 | 145 / 258 | 0% | 0.00 | 1 / 230 |
intestine | 50% | 15.96 | 480 / 966 | 3% | 0.06 | 18 / 527 |
stomach | 44% | 18.89 | 159 / 359 | 6% | 0.13 | 18 / 286 |
esophagus | 48% | 14.77 | 699 / 1445 | 2% | 0.08 | 4 / 183 |
pancreas | 33% | 11.57 | 109 / 328 | 13% | 0.19 | 23 / 178 |
ovary | 30% | 8.66 | 54 / 180 | 1% | 0.02 | 6 / 430 |
muscle | 27% | 5.77 | 219 / 803 | 0% | 0 | 0 / 0 |
brain | 24% | 5.44 | 636 / 2642 | 2% | 0.04 | 15 / 705 |
skin | 19% | 4.10 | 347 / 1809 | 1% | 0.04 | 6 / 472 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_0032692 | Biological process | negative regulation of interleukin-1 production |
GO_0032715 | Biological process | negative regulation of interleukin-6 production |
GO_0009968 | Biological process | negative regulation of signal transduction |
GO_0007165 | Biological process | signal transduction |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_0045751 | Biological process | negative regulation of Toll signaling pathway |
GO_0045345 | Biological process | positive regulation of MHC class I biosynthetic process |
GO_0032661 | Biological process | regulation of interleukin-18 production |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0036336 | Biological process | dendritic cell migration |
GO_1901223 | Biological process | negative regulation of non-canonical NF-kappaB signal transduction |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0071345 | Biological process | cellular response to cytokine stimulus |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0043281 | Biological process | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0070371 | Biological process | ERK1 and ERK2 cascade |
GO_0001818 | Biological process | negative regulation of cytokine production |
GO_0006915 | Biological process | apoptotic process |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0031953 | Biological process | negative regulation of protein autophosphorylation |
GO_0043122 | Biological process | regulation of canonical NF-kappaB signal transduction |
GO_0043124 | Biological process | negative regulation of canonical NF-kappaB signal transduction |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0008656 | Molecular function | cysteine-type endopeptidase activator activity involved in apoptotic process |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NLRP12 |
Protein name | NLR family pyrin domain containing 12 NACHT, LRR and PYD domains-containing protein 12 (Monarch-1) (PYRIN-containing APAF1-like protein 7) (Regulated by nitric oxide) |
Synonyms | RNO PYPAF7 NALP12 |
Description | FUNCTION: Plays an essential role as an potent mitigator of inflammation . Primarily expressed in dendritic cells and macrophages, inhibits both canonical and non-canonical NF-kappa-B and ERK activation pathways . Functions as a negative regulator of NOD2 by targeting it to degradation via the proteasome pathway . In turn, promotes bacterial tolerance . Inhibits also the RIGI-mediated immune signaling against RNA viruses by reducing the E3 ubiquitin ligase TRIM25-mediated 'Lys-63'-linked RIGI activation but enhancing the E3 ubiquitin ligase RNF125-mediated 'Lys-48'-linked RIGI degradation . Acts also as a negative regulator of inflammatory response to mitigate obesity and obesity-associated diseases in adipose tissue (By similarity). . |
Accessions | ENST00000324134.11 [P59046-1] ENST00000391773.7 [P59046-7] P59046 ENST00000345770.9 A0A0C4DH17 ENST00000391772.1 A0A0C4DFY3 ENST00000391775.7 [P59046-6] |